Nebenwirkungen · Inhixa
Inhixa 12,000 IU (120 mg)/0.8 mL solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 169–170
HOS-137122 · Präparat HOS-097950
169 Thrombocytopenia and thrombocytosis (see section 4.4 monitoring of platelet counts) System Prophylaxis Prophylaxi Treatment Extended Treatment in Treatment in organ class in surgical s in in patients treatment of patients with patients with patients medical with DVT DVT and PE unstable acute STEMI patients with or in patients angina and without PE with active non-Q-wave cancer MI Blood and Very Uncommon Very Unknown: Uncommon: Common: lymphatic common: : Thrombo- common: Thrombocyt Thrombo- Thrombocyto system Thrombocyto cytopenia Thrombo- openia cytopenia sisβ Thrombo- disorders sisβ cytosisβ cytopenia Very rare: Common: Immuno- Common: Thrombo- allergic Thrombo- cytopenia thrombo- cytopenia cytopenia β : Platelet increased > 400 G/L
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-16T09:35:00Z · SHA-256 bbb8302fcca3a170cc14307df6fa307c1fd979d2c3ae4a14f42ba825950d23d7 · Passage beb4c533aee9da38ba3a76d656e334892be2263459fbe3610edd0f1e36cf2349 · Zeichen 7431–9106 im Abschnitt